[1]
|
Ohnishi, H., Sugihara, J., Moriwaki, H., et al. (1995) [Acute-on-Chronic Liver Failure]. Ryoikibetsu Shokogun Shirizu, No. 7, 217-219.
|
[2]
|
Moreau, R., Jalan, R., Gines, P., et al. (2013) Acute-on-Chronic Liver Failure Is a Distinct Syndrome that Develops in Patients with Acute Decompensation of Cirrhosis. Gastroenterology, 144, 1426-1437. https://doi.org/10.1053/j.gastro.2013.02.042
|
[3]
|
Arroyo, V., Moreau, R. and Jalan, R. (2020) Acute-on-Chronic Liver Failure. The New England Journal of Medicine, 382, 2137-2145. https://doi.org/10.1056/NEJMra1914900
|
[4]
|
Verstak, B., Nagpal, K., Bottomley, S.P., et al. (2009) MyD88 Adapter-Like (Mal)/TIRAP Interaction with TRAF6 Is Critical for TLR2-and TLR4-Mediated NF-KappaB Proinflammatory Responses. The Journal of Biological Chemistry, 284, 24192-24203. https://doi.org/10.1074/jbc.M109.023044
|
[5]
|
Kayagaki, N., Wong, M.T., Stowe, I.B., et al. (2013) Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4. Science, 341, 1246-1249. https://doi.org/10.1126/science.1240248
|
[6]
|
Shi, J., Zhao, Y., Wang, Y., et al. (2014) Inflammatory Caspases Are Innate Immune Receptors for Intracellular LPS. Nature, 514, 187-192. https://doi.org/10.1038/nature13683
|
[7]
|
Elias, G., Schonfeld, M., Saleh, S., et al. (2023) Sepsis-Induced Endothelial Dysfunction Drives Acute-on-Chronic Liver Failure through Angiopoietin-2-HGF-C/EBPbeta Pathway. Hepatology, 78, 803-819. https://doi.org/10.1097/HEP.0000000000000354
|
[8]
|
Dominguez, M., Miquel, R., Colmenero, J., et al. (2009) Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients with Alcoholic Hepatitis. Gastroenterology, 136, 1639-1650. https://doi.org/10.1053/j.gastro.2009.01.056
|
[9]
|
Sarin, S.K., Pande, A. and Schnabl, B. (2019) Microbiome as a Therapeutic Target in Alcohol-Related Liver Disease. Journal of Hepatology, 70, 260-272. https://doi.org/10.1016/j.jhep.2018.10.019
|
[10]
|
Gustot, T. and Jalan, R. (2019) Acute-on-Chronic Liver Failure in Patients with Alcohol-Related Liver Disease. Journal of Hepatology, 70, 319-327. https://doi.org/10.1016/j.jhep.2018.12.008
|
[11]
|
Kim, Y.S. and Kim, S.G. (2020) Endoplasmic Reticulum Stress and Autophagy Dysregulation in Alcoholic and Non-Alcoholic Liver Diseases. Clinical and Molecular Hepatology, 26, 715-727. https://doi.org/10.3350/cmh.2020.0173
|
[12]
|
Dubuquoy, L., Louvet, A., Lassailly, G., et al. (2015) Progenitor Cell Expansion and Impaired Hepatocyte Regeneration in Explanted Livers from Alcoholic Hepatitis. Gut, 64, 1949-1960. https://doi.org/10.1136/gutjnl-2014-308410
|
[13]
|
Bhatti, T.K., Singal, A.K. and Kwo, P.Y. (2023) Viral Hepatitis and Acute-on-Chronic Liver Failure. Clinics in Liver Disease, 27, 617-630. https://doi.org/10.1016/j.cld.2023.03.006
|
[14]
|
Zhang, X., Zhang, Y., Zhou, P., et al. (2022) Down-Regulated Cylindromatosis Enhances NF-KappaB Activation and Aggravates Inflammation in HBV-ACLF Patients. Emerging Microbes & Infections, 11, 1586-1601. https://doi.org/10.1080/22221751.2022.2077128
|
[15]
|
Zhou, C., Zhang, N., He, T.T., et al. (2020) High Levels of Serum Interleukin-6 Increase Mortality of Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure. World Journal of Gastroenterology, 26, 4479-4488. https://doi.org/10.3748/wjg.v26.i30.4479
|
[16]
|
Zhu, B., Gao, F., Li, Y., et al. (2023) Serum Cytokine and Chemokine Profiles and Disease Prognosis in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Frontiers in Immunology, 14, Article 1133656. https://doi.org/10.3389/fimmu.2023.1133656
|
[17]
|
Martin-Mateos, R., Alvarez-Mon, M. and Albillos, A. (2019) Dysfunctional Immune Response in Acute-on-Chronic Liver Failure: It Takes Two to Tango. Frontiers in Immunology, 10, Article 973. https://doi.org/10.3389/fimmu.2019.00973
|
[18]
|
Zaccherini, G., Weiss, E. and Moreau, R. (2021) Acute-on-Chronic Liver Failure: Definitions, Pathophysiology and Principles of Treatment. JHEP Reports: Innovation in Hepatology, 3, Article 100176. https://doi.org/10.1016/j.jhepr.2020.100176
|
[19]
|
Iwasaki, A. and Medzhitov, R. (2015) Control of Adaptive Immunity by the Innate Immune System. Nature Immunology, 16, 343-353. https://doi.org/10.1038/ni.3123
|
[20]
|
Wu, J. and Chen, Z.J. (2014) Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids. Annual Review of Immunology, 32, 461-488. https://doi.org/10.1146/annurev-immunol-032713-120156
|
[21]
|
Albillos, A., De Gottardi, A. and Rescigno, M. (2020) The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy. Journal of Hepatology, 72, 558-577. https://doi.org/10.1016/j.jhep.2019.10.003
|
[22]
|
Arroyo, V., Angeli, P., Moreau, R., et al. (2021) The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. Journal of Hepatology, 74, 670-685. https://doi.org/10.1016/j.jhep.2020.11.048
|
[23]
|
Kou, K., Sun, X., Tian, G., et al. (2022) The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing. Journal of Immunology Research, 2022, Article ID: 5091275. https://doi.org/10.1155/2022/5091275
|
[24]
|
Xu, H., Yang, J., Gao, W., et al. (2014) Innate Immune Sensing of Bacterial Modifications of Rho GTPases by the Pyrin Inflammasome. Nature, 513, 237-241. https://doi.org/10.1038/nature13449
|
[25]
|
Bianchi, M.E. (2007) DAMPs, PAMPs and Alarmins: All We Need to Know about Danger. Journal of Leukocyte Biology, 81, 1-5. https://doi.org/10.1189/jlb.0306164
|
[26]
|
Wang, Y., Zhang, H., Chen, Q., et al. (2020) TNF-α/HMGB1 Inflammation Signalling Pathway Regulates Pyroptosis during Liver Failure and Acute Kidney Injury. Cell Proliferation, 53, e12829. https://doi.org/10.1111/cpr.12829
|
[27]
|
Murao, A., Aziz, M., Wang, H., et al. (2021) Release Mechanisms of Major DAMPs. Apoptosis: An International Journal on Programmed Cell Death, 26, 152-162. https://doi.org/10.1007/s10495-021-01663-3
|
[28]
|
Clària, J., Stauber, R.E., Coenraad, M.J., et al. (2016) Systemic Inflammation in Decompensated Cirrhosis: Characterization and Role in Acute-on-Chronic Liver Failure. Hepatology, 64, 1249-1264. https://doi.org/10.1002/hep.28740
|
[29]
|
Engelmann, C., Zhang, I.W. and Claria, J. (2023) Mechanisms of Immunity in Acutely Decompensated Cirrhosis and Acute-on-Chronic Liver Failure. Liver International. https://doi.org/10.1111/liv.15644
|
[30]
|
Bernardi, M., Moreau, R., Angeli, P., et al. (2015) Mechanisms of Decompensation and Organ Failure in Cirrhosis: From Peripheral Arterial Vasodilation to Systemic Inflammation Hypothesis. Journal of Hepatology, 63, 1272-1284. https://doi.org/10.1016/j.jhep.2015.07.004
|
[31]
|
Triantafyllou, E., Woollard, K.J., McPhail, M.J.W., et al. (2018) The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure. Frontiers in Immunology, 9, Article 2948. https://doi.org/10.3389/fimmu.2018.02948
|
[32]
|
Bernsmeier, C., Triantafyllou, E., Brenig, R., et al. (2018) CD14 CD15− HLA-DR− Myeloid-Derived Suppressor Cells Impair Antimicrobial Responses in Patients with Acute-on-Chronic Liver Failure. Gut, 67, 1155-1167. https://doi.org/10.1136/gutjnl-2017-314184
|
[33]
|
Bernsmeier, C., Pop, O.T., Singanayagam, A., et al. (2015) Patients with Acute-on-Chronic Liver Failure Have Increased Numbers of Regulatory Immune Cells Expressing the Receptor Tyrosine Kinase MERTK. Gastroenterology, 148, 603-615. https://doi.org/10.1053/j.gastro.2014.11.045
|
[34]
|
Wen, Y., Lambrecht, J., Ju, C., et al. (2021) Hepatic Macrophages in Liver Homeostasis and Diseases-Diversity, Plasticity and Therapeutic Opportunities. Cellular & Molecular Immunology, 18, 45-56. https://doi.org/10.1038/s41423-020-00558-8
|
[35]
|
Ogle, M.E., Segar, C.E., Sridhar, S., et al. (2016) Monocytes and Macrophages in Tissue Repair: Implications for Immunoregenerative Biomaterial Design. Experimental Biology and Medicine, 241, 1084-1097. https://doi.org/10.1177/1535370216650293
|
[36]
|
Grønbæk, H., Rødgaard-Hansen, S., Aagaard, N.K., et al. (2016) Macrophage Activation Markers Predict Mortality in Patients with Liver Cirrhosis without or with Acute-on-Chronic Liver Failure (ACLF). Journal of Hepatology, 64, 813-822. https://doi.org/10.1016/j.jhep.2015.11.021
|
[37]
|
Maras, J.S., Maiwall, R., Harsha, H.C., et al. (2015) Dysregulated Iron Homeostasis Is Strongly Associated with Multiorgan Failure and Early Mortality in Acute-on-Chronic Liver Failure. Hepatology, 61, 1306-1320. https://doi.org/10.1002/hep.27636
|
[38]
|
Metzemaekers, M., Gouwy, M. and Proost, P. (2020) Neutrophil Chemoattractant Receptors in Health and Disease: Double-Edged Swords. Cellular & Molecular Immunology, 17, 433-450. https://doi.org/10.1038/s41423-020-0412-0
|
[39]
|
Khanam, A., Trehanpati, N., Riese, P., et al. (2017) Blockade of Neutrophil’s Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure. Frontiers in Immunology, 8, Article 464. https://doi.org/10.3389/fimmu.2017.00464
|
[40]
|
Wieser, V., Adolph, T.E., Enrich, B., et al. (2017) Reversal of Murine Alcoholic Steatohepatitis by Pepducin-Based Functional Blockade of Interleukin-8 Receptors. Gut, 66, 930-938. https://doi.org/10.1136/gutjnl-2015-310344
|
[41]
|
Langer, M.M., Sichelschmidt, S., Bauschen, A., et al. (2023) Pathological Neutrophil Migration Predicts Adverse Outcomes in Hospitalized Patients with Liver Cirrhosis. Liver International, 43, 896-905. https://doi.org/10.1111/liv.15486
|
[42]
|
Garfia, C., García-Ruiz, I. and Solís-Herruzo, J.A. (2004) Deficient Phospholipase C Activity in Blood Polimorphonuclear Neutrophils from Patients with Liver Cirrhosis. Journal of Hepatology, 40, 749-756. https://doi.org/10.1016/j.jhep.2004.01.004
|
[43]
|
Boussif, A., Rolas, L., Weiss, E., et al. (2016) Impaired Intracellular Signaling, Myeloperoxidase Release and Bactericidal Activity of Neutrophils from Patients with Alcoholic Cirrhosis. Journal of Hepatology, 64, 1041-1048. https://doi.org/10.1016/j.jhep.2015.12.005
|
[44]
|
Sherman, M.H. (2018) Stellate Cells in Tissue Repair, Inflammation, and Cancer. Annual Review of Cell and Developmental Biology, 34, 333-355. https://doi.org/10.1146/annurev-cellbio-100617-062855
|
[45]
|
Rastogi, A., Bihari, C., Maiwall, R., et al. (2012) Hepatic Stellate Cells Are Involved in the Pathogenesis of Acute-on-Chronic Liver Failure (ACLF). Virchows Archiv, 461, 393-398. https://doi.org/10.1007/s00428-012-1291-2
|
[46]
|
Lopez-Sanchez, G.N., Dominguez-Perez, M., Uribe, M., et al. (2020) The Fibrogenic Process and the Unleashing of Acute-on-Chronic Liver Failure. Clinical and Molecular Hepatology, 26, 7-15. https://doi.org/10.3350/cmh.2019.0011
|
[47]
|
Katoonizadeh, A., Laleman, W., Verslype, C., et al. (2010) Early Features of Acute-on-Chronic Alcoholic Liver Failure: A Prospective Cohort Study. Gut, 59, 1561-1569. https://doi.org/10.1136/gut.2009.189639
|
[48]
|
Hotchkiss, R.S. and Nicholson, D.W. (2006) Apoptosis and Caspases Regulate Death and Inflammation in Sepsis. Nature Reviews Immunology, 6, 813-822. https://doi.org/10.1038/nri1943
|
[49]
|
Tazi, K.A., Bièche, I., Paradis, V., et al. (2007) In vivo Altered Unfolded Protein Response and Apoptosis in Livers from Lipopolysaccharide-Challenged Cirrhotic Rats. Journal of Hepatology, 46, 1075-1088. https://doi.org/10.1016/j.jhep.2007.01.034
|
[50]
|
Claria, J., Arroyo, V. and Moreau, R. (2023) Roles of Systemic Inflammatory and Metabolic Responses in the Pathophysiology of Acute-on-Chronic Liver Failure. JHEP Reports: Innovation in Hepatology, 5, Article 100807. https://doi.org/10.1016/j.jhepr.2023.100807
|
[51]
|
Caraceni, P., Riggio, O., Angeli, P., et al. (2018) Long-Term Albumin Administration in Decompensated Cirrhosis (ANSWER): An Open-Label Randomised Trial. The Lancet, 391, 2417-2429. https://doi.org/10.1016/S0140-6736(18)30840-7
|
[52]
|
Fernandez, J., Claria, J., Amoros, A., et al. (2019) Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients with Decompensated Cirrhosis. Gastroenterology, 157, 149-162. https://doi.org/10.1053/j.gastro.2019.03.021
|
[53]
|
Bernardi, M., Angeli, P., Claria, J., et al. (2020) Albumin in Decompensated Cirrhosis: New Concepts and Perspectives. Gut, 69, 1127-1138. https://doi.org/10.1136/gutjnl-2019-318843
|
[54]
|
Pande, G., Hatti, M., Rai, M.K., et al. (2022) Response Guided Slow Infusion of Albumin, Vasoconstrictors and Furosemide Improves Ascites Mobilization and Survival in Acute-on-Chronic Liver Failure: A Proof-of-Concept Study. Journal of Inflammation Research, 15, 5027-5039. https://doi.org/10.2147/JIR.S377494
|
[55]
|
Sort, P., Navasa, M., Arroyo, V., et al. (1999) Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis. The New England Journal of Medicine, 341, 403-409. https://doi.org/10.1056/NEJM199908053410603
|
[56]
|
Fernandez, J., Angeli, P., Trebicka, J., et al. (2020) Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Clinical Gastroenterology and Hepatology, 18, 963-973.
|
[57]
|
Banares, R., Ibanez-Samaniego, L., Torner, J.M., et al. (2019) Meta-Analysis of Individual Patient Data of Albumin Dialysis in Acute-on-Chronic Liver Failure: Focus on Treatment Intensity. Therapeutic Advances in Gastroenterology, 12, 1-12. https://doi.org/10.1177/1756284819879565
|
[58]
|
Niewinski, G., Raszeja-Wyszomirska, J., Hrenczuk, M., et al. (2020) Intermittent High-Flux Albumin Dialysis with Continuous Venovenous Hemodialysis for Acute-on-Chronic Liver Failure and Acute Kidney Injury. Artificial Organs, 44, 91-99. https://doi.org/10.1111/aor.13532
|
[59]
|
Xiang, X., Feng, D., Hwang, S., et al. (2020) Interleukin-22 Ameliorates Acute-on-Chronic Liver Failure by Reprogramming Impaired Regeneration Pathways in Mice. Journal of Hepatology, 72, 736-745. https://doi.org/10.1016/j.jhep.2019.11.013
|
[60]
|
Hwang, S., Hicks, A., Hoo, C.Z., et al. (2023) Novel Treatment of Acute and Acute-on-Chronic Liver Failure: Interleukin-22. Liver International. https://doi.org/10.1111/liv.15619
|
[61]
|
Engelmann, C., Sheikh, M., Sharma, S., et al. (2020) Toll-Like Receptor 4 Is a Therapeutic Target for Prevention and Treatment of Liver Failure. Journal of Hepatology, 73, 102-112. https://doi.org/10.1016/j.jhep.2020.01.011
|
[62]
|
He, Y., Guo, X., Lan, T., et al. (2021) Human Umbilical Cord-Derived Mesenchymal Stem Cells Improve the Function of Liver in Rats with Acute-on-Chronic Liver Failure via Downregulating Notch and Stat1/Stat3 Signaling. Stem Cell Research & Therapy, 12, Article 396. https://doi.org/10.1186/s13287-021-02468-6
|